Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids, and Neuroinflammation in HIV

NCT05514899 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT05514899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05514899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids, and Neuroinflammation in HIV
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Recruiting
Start date
September 1, 2023
Completion date
October 31, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis, hiv, microbiome, neuroinflammatory disease, neuroinflammatory response, thc